TY  - RPRT
TI  - Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
AU  - Rebecca B. Silva
AU  - Bin Cheng
AU  - Shing M. Lee
PY  - 2025
UR  - https://arxiv.org/abs/2504.14622
ID  - 2504.14622
ER  -